Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics. (2022)

First Author: El Eid L
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2022.106411

PubMed Identifier: 36007775

Publication URI: http://europepmc.org/abstract/MED/36007775

Type: Journal Article/Review

Volume: 184

Parent Publication: Pharmacological research

ISSN: 1043-6618